Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FBNQW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for the supply of Stelara 90 mg/ml syringes. The contract is issued under a firm fixed-price arrangement with an ultimate completion date of October 3, 2025, and represents a non-set-aside award. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
Stelara, a biologic immunosuppressant medication, will be distributed to military health facilities as part of the DLA's mission to maintain pharmaceutical supply chains for federal healthcare systems. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively across multiple pharmaceutical product categories including specialty biologics, oncology treatments, vaccines, and medical consumables. The company's consistent contract awards with the DLA demonstrate its reliability and capacity to deliver specialized pharmaceutical products to support military medical operations.
Quick answers
Who was awarded contract SPE2DB25FBNQW?
SPE2DB25FBNQW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FBNQW worth?
The government has obligated $16,250 on SPE2DB25FBNQW.
Is contract SPE2DB25FBNQW an order under another contract?
Yes. SPE2DB25FBNQW is a delivery order under SPE2DB24D9211, an indefinite delivery contract.
Was contract SPE2DB25FBNQW competed?
The extent of competition for SPE2DB25FBNQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award